Cointime update: WuXi Juwel’s CAR-T product Relma-cel (brand name: Benlysta) has entered China’s National Basic Medical Insurance catalogue, making it the first and currently only CAR-T therapy covered by the national scheme. Industry sources estimate the negotiated price at under 300,000 yuan, with patients’ out-of-pocket cost potentially below 100,000 yuan after reimbursement.
WuXi Juwel’s CAR-T Therapy Becomes First in China’s National Basic Medical Insurance
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
37m ago
Etherscan Flags Unauthorized Access Attempt on Support Ticket System
39m ago
Goldman Sachs’ Ethereum ETF Holdings Rise to $1.22B in Q3, ETHA Stake Up 352%
1h ago
Charles Schwab Adds 749,566 Strive Shares Worth $77.2M
1h ago
US Compute-Cloud Stocks Rise in Pre-Market Trading
2h ago
Binance Hot Wallet Attacker Moves 78,415 ETH Worth $142M
2h ago
Binance Plans to Enter Five Asian Markets Next Year, Focus on South and Southeast Asia